NR3C2 and atrial fibrillation: The baseline characteristics of the 2 groups after PS-matched analysis were similar, except for AF duration and prevalence of implantable cardioverter defibrillators, mineralocorticoid receptor antagonists, and class III antiarrhythmic drugs (eTable 5 in Supplement 1).